Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2016
Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering
Chungang Gu, Michelle L Lamb, Jeffrey W Johannes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2019
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells
Justin Cidado, Scott Boiko, Theresa Proia, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
James E Dowling, Claudio Chuaqui, Timothy W Pontz, et al.
Endocrine
|
November 20, 2023
Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis
Chun Ho Wong, Andy Ka Chun Kan, Kimberly Hang Tsoi, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
June 13, 2025
Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center
Chun Ho Wong, Kimberly Hang Tsoi, Jingya Jane Pu, et al.
Cancer Research
|
October 10, 2018
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer
Zebin Wang, Shaun E Grosskurth, Tony Cheung, et al.
Chemmedchem
|
December 22, 2017
Structure-Based Design of Selective Noncovalent CDK12 Inhibitors
Jeffrey W Johannes, Christopher R Denz, Nancy Su, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1
Simon C C Lucas, Alexander G Milbradt, J Henry Blackwell, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 8, 2015
Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering
Jeffrey W Johannes, Lynsie Almeida, Kevin Daly, et al.
Journal of Medicinal Chemistry
|
September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors
Simon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2016
Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering
Chungang Gu, Michelle L Lamb, Jeffrey W Johannes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2019
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells
Justin Cidado, Scott Boiko, Theresa Proia, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
James E Dowling, Claudio Chuaqui, Timothy W Pontz, et al.
Endocrine
|
November 20, 2023
Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis
Chun Ho Wong, Andy Ka Chun Kan, Kimberly Hang Tsoi, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
June 13, 2025
Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center
Chun Ho Wong, Kimberly Hang Tsoi, Jingya Jane Pu, et al.
Cancer Research
|
October 10, 2018
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer
Zebin Wang, Shaun E Grosskurth, Tony Cheung, et al.
Chemmedchem
|
December 22, 2017
Structure-Based Design of Selective Noncovalent CDK12 Inhibitors
Jeffrey W Johannes, Christopher R Denz, Nancy Su, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1
Simon C C Lucas, Alexander G Milbradt, J Henry Blackwell, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 8, 2015
Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering
Jeffrey W Johannes, Lynsie Almeida, Kevin Daly, et al.
Journal of Medicinal Chemistry
|
September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors
Simon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Page
of 3